249 related articles for article (PubMed ID: 7991123)
1. Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds.
van Geel BM; Assies J; Weverling GJ; Barth PG
Neurology; 1994 Dec; 44(12):2343-6. PubMed ID: 7991123
[TBL] [Abstract][Full Text] [Related]
2. X-linked adrenoleukodystrophy: phenotype distribution and expression of ALDP in Spanish kindreds.
Ruiz M; Coll MJ; Pàmpols T; Girós M
Am J Med Genet; 1998 Apr; 76(5):424-7. PubMed ID: 9556303
[TBL] [Abstract][Full Text] [Related]
3. X-linked adrenomyeloneuropathy associated with 14 novel ALD-gene mutations: no correlation between type of mutation and age of onset.
Wichers M; Köhler W; Brennemann W; Boese V; Sokolowski P; Bidlingmaier F; Ludwig M
Hum Genet; 1999; 105(1-2):116-9. PubMed ID: 10480364
[TBL] [Abstract][Full Text] [Related]
4. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy.
Lazo O; Contreras M; Hashmi M; Stanley W; Irazu C; Singh I
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7647-51. PubMed ID: 3174658
[TBL] [Abstract][Full Text] [Related]
5. Therapy of X-linked adrenoleukodystrophy.
Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
[TBL] [Abstract][Full Text] [Related]
6. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients.
Laureti S; Casucci G; Santeusanio F; Angeletti G; Aubourg P; Brunetti P
J Clin Endocrinol Metab; 1996 Feb; 81(2):470-4. PubMed ID: 8636252
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features and genotype-phenotype studies of 89 Chinese patients with X-linked adrenoleukodystrophy].
Ping LL; Bao XH; Wang AH; Pan H; Wu Y; Xiong H; Jiang YW; Qin J; Wu XR
Zhonghua Er Ke Za Zhi; 2007 Mar; 45(3):203-7. PubMed ID: 17504626
[TBL] [Abstract][Full Text] [Related]
8. [X-linked adrenoleukodystrophy].
Aubourg P
Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
[TBL] [Abstract][Full Text] [Related]
9. Integrative lipidomic and transcriptomic analysis of X-linked adrenoleukodystrophy reveals distinct lipidome signatures between adrenomyeloneuropathy and childhood cerebral adrenoleukodystrophy.
Lee DK; Long NP; Jung J; Kim TJ; Na E; Kang YP; Kwon SW; Jang J
Biochem Biophys Res Commun; 2019 Jan; 508(2):563-569. PubMed ID: 30509496
[TBL] [Abstract][Full Text] [Related]
10. Identification of mutations in the ALD-gene of 20 families with adrenoleukodystrophy/adrenomyeloneuropathy.
Krasemann EW; Meier V; Korenke GC; Hunneman DH; Hanefeld F
Hum Genet; 1996 Feb; 97(2):194-7. PubMed ID: 8566952
[TBL] [Abstract][Full Text] [Related]
11. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
[TBL] [Abstract][Full Text] [Related]
12. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy.
Pujol A; Hindelang C; Callizot N; Bartsch U; Schachner M; Mandel JL
Hum Mol Genet; 2002 Mar; 11(5):499-505. PubMed ID: 11875044
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA Profiling Identifies miR-196a as Differentially Expressed in Childhood Adrenoleukodystrophy and Adult Adrenomyeloneuropathy.
Shah N; Singh I
Mol Neurobiol; 2017 Mar; 54(2):1392-1403. PubMed ID: 26843114
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients.
Jang J; Kang HC; Kim HS; Kim JY; Huh YJ; Kim DS; Yoo JE; Lee JA; Lim B; Lee J; Yoon TM; Park IH; Hwang DY; Daley GQ; Kim DW
Ann Neurol; 2011 Sep; 70(3):402-9. PubMed ID: 21721033
[TBL] [Abstract][Full Text] [Related]
15. [Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy].
Stradomska TJ; Tylki-Szymańska A
Pediatr Pol; 1996 Mar; 71(3):197-201. PubMed ID: 8966090
[TBL] [Abstract][Full Text] [Related]
16. [Adrenoleukodystrophy and adrenomyeloneuropathy--clinical spectrum, pathobiochemical aspects, diagnosis and therapy].
Zierz S; Tackmann W
Fortschr Neurol Psychiatr; 1989 Dec; 57(12):527-34. PubMed ID: 2559009
[TBL] [Abstract][Full Text] [Related]
17. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy.
van Geel BM; Bezman L; Loes DJ; Moser HW; Raymond GV
Ann Neurol; 2001 Feb; 49(2):186-94. PubMed ID: 11220738
[TBL] [Abstract][Full Text] [Related]
18. Reproductive function in men affected by X-linked adrenoleukodystrophy/adrenomyeloneuropathy.
Stradomska TJ; Kubalska J; Janas R; Tylki-Szymanska A
Eur J Endocrinol; 2012 Feb; 166(2):291-4. PubMed ID: 22048970
[TBL] [Abstract][Full Text] [Related]
19. [X-linked adrenoleukodystrophy--2 case reports].
Dumić M; Ille J; Plavsić V; Filipović-Grcić B; Vrljicak K; Barisić N; Roscher A
Lijec Vjesn; 1998; 120(1-2):19-23. PubMed ID: 9650481
[TBL] [Abstract][Full Text] [Related]
20. Typical and atypical phenotype and neuroimaging of X-linked adrenoleukodystrophy in a Chinese cohort.
Mao C; Li J; Huang X; Wang J; Chu S; Zhang Y; Dong L; Liu C; Lu L; Qiu L; Chen W; Peng B; Cui L; Gao J
Neurol Sci; 2022 May; 43(5):3255-3263. PubMed ID: 34997422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
